HONG KONG – A small Chinese biopharmaceutical company expects that the support and resources of a traditional Chinese medicine (TCM)and active pharmaceutical ingredients manufacturer will help it develop a stronger biologics pipeline.
HONG KONG – A leading Indian biosimilars maker reported a slight decline in biopharma sales in the quarter ending June 30, affected by the chaotic situation in the Middle East.
HONG KONG – A leading Indian biosimilars maker reported a slight decline in biopharma sales in the quarter ending June 30, affected by the chaotic situation in the Middle East.
HONG KONG – Leading Chinese vaccine maker Sinovac Biotech Ltd. (NASDAQ:SVA) has emerged as the sole supplier of hepatitis A vaccine in prefilled syringe dosages for the city of Beijing.
HONG KONG – Leading Chinese vaccine maker Sinovac Biotech Ltd. (NASDAQ:SVA) has emerged as the sole supplier of hepatitis A vaccine in prefilled syringe dosages for the city of Beijing.
HONG KONG – A Guangzhou-based biotech company is working with one of the most prestigious universities in China to build a new institute and raise a fund to drive the development of stem cell and regenerative medicine projects.
HONG KONG – A Guangzhou-based biotech company is working with one of the most prestigious universities in China to build a new institute and raise a fund to drive the development of stem cell and regenerative medicine projects.
HONG KONG – Starting this month, Chinese biotech companies will enjoy a 50 percent reduction in value-added tax (VAT) in China, all part of a government plan to standardize taxes across the country.
